Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 143

1.

Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women.

Hitchcock CL, Prior JC.

Menopause. 2012 Aug;19(8):886-93. doi: 10.1097/gme.0b013e318247f07a.

PMID:
22453200
[PubMed - indexed for MEDLINE]
2.

Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women.

Hitchcock CL, Elliott TG, Norman EG, Stajic V, Teede H, Prior JC.

Menopause. 2012 Nov;19(11):1208-14. doi: 10.1097/gme.0b013e31825541cc.

PMID:
22781788
[PubMed - indexed for MEDLINE]
3.

Progesterone for hot flush and night sweat treatment--effectiveness for severe vasomotor symptoms and lack of withdrawal rebound.

Prior JC, Hitchcock CL.

Gynecol Endocrinol. 2012 Oct;28 Suppl 2:7-11. Epub 2012 Aug 1.

PMID:
22849758
[PubMed - indexed for MEDLINE]
4.

Progesterone therapy increases free thyroxine levels--data from a randomized placebo-controlled 12-week hot flush trial.

Sathi P, Kalyan S, Hitchcock CL, Pudek M, Prior JC.

Clin Endocrinol (Oxf). 2013 Aug;79(2):282-7. doi: 10.1111/cen.12128. Epub 2013 May 6.

PMID:
23252963
[PubMed - indexed for MEDLINE]
5.

Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.

Joffe H, Guthrie KA, Larson J, Cohen LS, Carpenter JS, Lacroix AZ, Freeman EW.

Menopause. 2013 Mar;20(3):261-8. doi: 10.1097/GME.0b013e31826d3108.

PMID:
23435022
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The effects of micronutrient supplementation on vasomotor symptoms in postmenopausal women.

Andrikoula M, Baker D, Nesic J, Liao LM, Duka T, Prelevic GM.

Climacteric. 2011 Oct;14(5):544-50. doi: 10.3109/13697137.2011.558951. Epub 2011 Mar 17.

PMID:
21413865
[PubMed - indexed for MEDLINE]
7.

A double-blind placebo-controlled study to evaluate the effect of progestelle progesterone cream on postmenopausal women.

Benster B, Carey A, Wadsworth F, Vashisht A, Domoney C, Studd J.

Menopause Int. 2009 Jun;15(2):63-9. doi: 10.1258/mi.2009.009014.

PMID:
19465671
[PubMed - indexed for MEDLINE]
8.

Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.

Joffe H, Guthrie KA, LaCroix AZ, Reed SD, Ensrud KE, Manson JE, Newton KM, Freeman EW, Anderson GL, Larson JC, Hunt J, Shifren J, Rexrode KM, Caan B, Sternfeld B, Carpenter JS, Cohen L.

JAMA Intern Med. 2014 Jul;174(7):1058-66. doi: 10.1001/jamainternmed.2014.1891.

PMID:
24861828
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

[Evaluation the efficacy and safety of estradiol and drospirenone tablets in the treatment of menopausal symptoms among postmenopausal Chinese healthy women:a randomized, multi-center, double-blind, placebo-controlled clinical study].

Zhou YZ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Lin SQ.

Zhonghua Fu Chan Ke Za Zhi. 2011 May;46(5):345-9. Chinese.

PMID:
21733370
[PubMed - indexed for MEDLINE]
10.

Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.

Pinkerton JV, Constantine G, Hwang E, Cheng RF; Study 3353 Investigators.

Menopause. 2013 Jan;20(1):28-37. doi: 10.1097/gme.0b013e31826421a8.

PMID:
23010882
[PubMed - indexed for MEDLINE]
11.

Estradiol 1 mg and drospirenone 2 mg as hormone replacement therapy in postmenopausal Chinese women.

Lin SQ, Sun LZ, Lin JF, Yang X, Zhang LJ, Qiao J, Wang ZH, Xu YX, Xiong ZA, Zhou YZ, Wang ML, Zhu J, Chen SR, Su H, Yang CS, Wang SH, Zhang YZ, Dong XJ.

Climacteric. 2011 Aug;14(4):472-81. doi: 10.3109/13697137.2011.553971. Epub 2011 Apr 6.

PMID:
21469973
[PubMed - indexed for MEDLINE]
12.
13.

Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial.

Van Patten CL, Olivotto IA, Chambers GK, Gelmon KA, Hislop TG, Templeton E, Wattie A, Prior JC.

J Clin Oncol. 2002 Mar 15;20(6):1449-55.

PMID:
11896091
[PubMed - indexed for MEDLINE]
14.

Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trial.

Bachmann GA, Schaefers M, Uddin A, Utian WH.

Obstet Gynecol. 2007 Oct;110(4):771-9.

PMID:
17906008
[PubMed - indexed for MEDLINE]
15.

Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.

Freeman EW, Guthrie KA, Caan B, Sternfeld B, Cohen LS, Joffe H, Carpenter JS, Anderson GL, Larson JC, Ensrud KE, Reed SD, Newton KM, Sherman S, Sammel MD, LaCroix AZ.

JAMA. 2011 Jan 19;305(3):267-74. doi: 10.1001/jama.2010.2016.

PMID:
21245182
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Oral estrogen replacement therapy versus placebo for hot flushes: a systematic review.

MacLennan A, Lester S, Moore V.

Climacteric. 2001 Mar;4(1):58-74.

PMID:
11379379
[PubMed - indexed for MEDLINE]
17.

Efficacy and tolerability of desvenlafaxine succinate treatment for menopausal vasomotor symptoms: a randomized controlled trial.

Speroff L, Gass M, Constantine G, Olivier S; Study 315 Investigators.

Obstet Gynecol. 2008 Jan;111(1):77-87. doi: 10.1097/01.AOG.0000297371.89129.b3.

PMID:
18165395
[PubMed - indexed for MEDLINE]
18.

Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.

Aldrighi JM, Quail DC, Levy-Frebault J, Aguas F, Kosian K, Garrido L, Bosio-Le Goux B, Saráchaga M, Graebe A, Niño AJ, Nickelsen T.

Am J Obstet Gynecol. 2004 Dec;191(6):1979-88.

PMID:
15592280
[PubMed - indexed for MEDLINE]
19.

The effects of Chinese medicinal herbs on postmenopausal vasomotor symptoms of Australian women. A randomised controlled trial.

Davis SR, Briganti EM, Chen RQ, Dalais FS, Bailey M, Burger HG.

Med J Aust. 2001 Jan 15;174(2):68-71.

PMID:
11245505
[PubMed - indexed for MEDLINE]
20.

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.

Pinkerton JV, Utian WH, Constantine GD, Olivier S, Pickar JH.

Menopause. 2009 Nov-Dec;16(6):1116-24. doi: 10.1097/gme.0b013e3181a7df0d.

PMID:
19546826
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk